The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.

Pinpoint has launched its software engineering analytics platform following a $13.5m round that featured Bloomberg Beta and Slack Fund.

Axovant spinoff Arvelle Therapeutics received $180m in the LSP-led series A round, and will focus on the development of a recently licensed epilepsy drug.

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

The environmental microbiome testing kit maker has collected capital from investors including Western Digital Capital, 3M Ventures and Agfunder in its series A round.

Passage Bio has launched to develop treatments for diseases affecting the central nervous system, after raising almost $116m in a series A round backed by Lilly Asia Ventures.

Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.

Legend Capital led a $29.5m round for SciWind, which is developing treatments for metabolic and liver diseases, with backing from Kawin Technology.

Geothermal heating and cooling system provider Dandelion Energy received $16m in a Comcast Ventures-led round that included GV and Lennar.